Friday 26th August, 2016   |   Welcome, guest. Please, login or register  
Tuesday April 26, 15:01

Alzheimer's: The real signals for a correct diagnosis

Alzheimer's disease: non-drug treatment is always possible. (credit: lefigaro)
Alzheimer's disease: non-drug treatment is always possible. (credit: lefigaro)

A woman aged 85 years is often mistaken dates, names sometimes, regularly repeats the same phrases. Her daughter, a doctor, suspected early Alzheimer's. Should we consult? Make tests? Wait a precise medical diagnosis?

The National Institute of Aging in the United States announced last week for the first time in twenty-seven years, new guidelines for the diagnosis of Alzheimer's disease, dementia the most common among the elderly. These recommendations are based on four articles to be published in May in the journal Alzheimer's & Dementia, which sets out the criteria for asserting the presence of the disease.

Without effective treatment, why wear a precise diagnosis of this disease? On the one hand, physicians responded that a non-drug treatment (stimulation, support, anticipation of a future organization of lifestyle) is always possible. Importantly, these recommendations classify the disease in three different stages, preclinical (asymptomatic), mild cognitive impairment (memory impairment limited) and finally dementia (final stage of the disease). While their interest is to define the tools to detect early forms of harmonized manner with the aim to conduct large scale clinical trials on large groups and homogeneous patient meeting the same diagnostic criteria.

These recommendations will be useful in diagnosing patients, for a start therapy, when effective drugs will be available. But we're not there yet.

The new guidelines cover all stages of the disease which evolves very gradually over several years. It may in fact cause changes in the brain a decade or more before it becomes obvious.

Recommendations hold three phases

The first, entitled "Preclinical" before the disease symptoms are evident, is that where changes occur in the brain and in particular an early accumulation of senile plaques composed of a protein capable of causing death neurons. At this stage, abnormalities in the cerebrospinal fluid (obtained by lumbar puncture) and anatomical damage detectable by brain imaging (MRI, PET scan) are already visible. However, many uncertainties exist about the long-term significance of these signs.

The second phase is the first sign (mild cognitive impairment), such as memory loss, but without significant impact on the independence of the individual concerned. "People with these symptoms will not necessarily see a move towards Alzheimer's disease," say the authors of these guidelines.


The third and last phase is that of dementia as previously described by medicine, memory loss, loss of learning, confusion, disorientation in time and space, dependence.

Researchers use more biomarkers (measured in blood or cerebrospinal fluid) in the early stages of the disease in their quest to track the evolution of evil. They can not be used routinely, especially due to inadequate validation.

Early clinical criteria for Alzheimer officially established in 1984 described this condition in one stage of dementia. We had to wait for the autopsy showing an aggregation of amyloid plaques and tau protein in some areas of the brain to confirm the diagnosis.

The disorder first described in 1907 by German psychiatrist Alois Alzheimer's most often appears after age 65. Its frequency increases with age.


Most recent in the category Diseases:


Last comments


No comments. Be the first to comment the article!

Please, login or post your comment anonymously.

Your comment:


Home | Social Health | AIDS | Cancer | Diseases | Diet | Human body | Most read | Top rated

RSS | Feedback | Headlines for your website | Terms of Service/Privacy policy

Copyright © 2016 All rights reserved.